RecruitingPhase 4NCT06121466
Effect of Abdominal Wall Injections on Abdominal Pain
Sponsor
Oregon Health and Science University
Enrollment
45 participants
Start Date
Jan 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at the outpatient gastroenterology clinic at OHSU.
Eligibility
Min Age: 18 YearsMax Age: 100 Years
Inclusion Criteria5
- Localized abdominal wall pain
- Average daily pain (7-day recall) ≥ 3 on a scale of 0-10
- Suspected abdominal wall etiology for abdominal pain
- Positive Carnett's sign or pain near an incisional site
- years of age or older
Exclusion Criteria8
- Suspected visceral etiology for the abdominal pain
- Severe allergy to lidocaine
- Unwillingness or inability to provide informed consent
- Low probability of follow-up
- Abdominal wall hernia noted at the point of pain
- History of trigger point injections for abdominal pain
- Bleeding disorder
- Pregnancy, incarceration or decisionally impaired
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGAbdominal wall injections with lidocaine 2%
Injections will be administered for patient who are identified as having abdominal wall pain.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06121466